Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis. [electronic resource]
Producer: 20201009Description: 783-795 p. digitalISSN:- 1755-5949
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- analogs & derivatives
- Administration, Intranasal
- Animals
- Cell- and Tissue-Based Therapy -- methods
- Encephalomyelitis, Autoimmune, Experimental -- metabolism
- Female
- Leukocytes, Mononuclear -- drug effects
- Mice, Inbred C57BL
- Myelin-Oligodendrocyte Glycoprotein
- Peptide Fragments
- Protein Kinase Inhibitors -- pharmacology
- Spinal Cord -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.